Manoranjenni Chetty

Application of a Physiologically Based Pharmacokinetic Model to Predict <i>OATP1B1</i>‐Related Variability in Pharmacodynamics of Rosuvastatin

RH Rose, Sibylle Neuhoff, Khaled Abduljalil et al. · CPT Pharmacometrics & Systems Pharmacology · 2014 · 74 citations · Full text

Pd Response, Pharmacotherapy, Physiologically-based Pharmacokinetic Modeling +17

Applications of linking PBPK and PD models to predict the impact of genotypic variability, formulation differences, differences in target binding capacity and target site drug concentrations on drug responses and variability

Manoranjenni Chetty, Rachel H. Rose, Khaled Abduljalil et al. · Frontiers in Pharmacology · 2014 · 58 citations · Full text

Sex Differences in the Clearance of CYP3A4 Substrates: Exploring Possible Reasons for the Substrate Dependency and Lack of Consensus

Manoranjenni Chetty, Donald R. Mattison, Amin Rostami‐Hodjegan · Current Drug Metabolism · 2012 · 42 citations

A High-Throughput Assay Using Liquid Chromatography-Tandem Mass Spectrometry for Simultaneous In Vivo Phenotyping of 5 Major Cytochrome P450 Enzymes in Patients

Sussan Ghassabian, Manoranjenni Chetty, Bruce N. Tattam et al. · Therapeutic Drug Monitoring · 2009 · 40 citations

Vivo Phenotyping, Metabolomic Profiling, Psychopharmacology +20

Smoking and body weight influence the clearance of chlorpromazine

Manoranjenni Chetty, R. Miller, S.V. Moodley · European Journal of Clinical Pharmacology · 1994 · 35 citations

Tobacco Control, Body Weight Influence, Tobacco Use +5